Dr. Anthony Fauci, the top infectious diseases expert in the United States, is also one of the most visible members of the White House coronavirus task force. In a recent interview, Fauci said that his meetings with President Donald Trump have “dramatically decreased” recently.
In an interview with Stat new, Dr. Fauci was asked if he is in frequent contact with President Donald Trump to give the POTUS updates on the coronavirus vaccine development. However, the National Institute for Allergies and Infectious Disease director explained that Trump has decreased his meetings with Fauci recently.
“We used to have task force meetings every single day, including Saturday and Sunday, and about 75% of the time after the task force meeting we'd meet with the president,” Fauci said, according to Business Insider. “So I was meeting with him four times a week back, a month or so ago.”
Dr. Fauci added that his meetings with President Donald Trump have become less frequent lately. “But as you probably noticed, that the task force meetings have not occurred as often lately,” the health expert added. “And certainly my meetings with the president have been dramatically decreased.”
In May, the White House hinted that the coronavirus task force would be dissolved, according to The Hill. However, President Donald Trump later decided that it will remain in place “indefinitely” after the original plan to dissolve it faced public backlash.
Dr. Fauci also expressed optimism that a coronavirus vaccine will eventually be found. “What I like about the whole thing is that there are multiple candidates that we’re involved with,” he said.
“It just feels good to be directly or indirectly involved in four or five candidates, to do it in a way that I refer to as sort of harmonized, where you come to an agreement, which we did, that we’re going to do things where the trial protocols will be quite similar, where the laboratory tests that we’re going to ask for are going to be quite similar so that you can extrapolate results from one study to another,” the National Institute of Allergy and Infectious Diseases said.
Dr. Fauci previously said that a vaccine might be available later this year. “I think that the president and the administration would be really very happy if we had a vaccine that we could deploy by the end of this year,” he said.


Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Jack Lang Resigns as Head of Arab World Institute Amid Epstein Controversy
Nighttime Shelling Causes Serious Damage in Russia’s Belgorod Region Near Ukraine Border
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Ohio Man Indicted for Alleged Threat Against Vice President JD Vance, Faces Additional Federal Charges
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Pentagon Ends Military Education Programs With Harvard University
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



